Research map: All Together Now
Back to the article
Papers in this map
- The 2019 WHO classification of tumours of the digestive system · Irıs D. Nagtegaal · 2019 · 4271 citations · Cited by this paper
- Pathology Clinics Can Address Pathology Burnout · 2025 · Related
- Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States · Arvind N. Dasari · 2017 · 3539 citations · Cited by this paper
- Review of Established and Emerging Infectious Diseases in Transfusion Medicine · 2025 · Related
- Placebo-Controlled, Double-Blind, Prospective, Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients With Metastatic Neuroendocrine Midgut Tumors: A Report From the PROMID Study Group · Anja Rinke · 2009 · 2528 citations · Cited by this paper
- Advances in Clinical Toxicology Testing · 2025 · Related
- Comprehensive genomic profiles of small cell lung cancer · Julie George · 2015 · 2447 citations · Cited by this paper
- Hemostatic Disorders Following Severe Acute Respiratory Syndrome Coronavirus 2 Infection, COVID-19 Vaccination, and Long-COVID Syndrome · 2025 · Related
- Lanreotide in Metastatic Enteropancreatic Neuroendocrine Tumors · Martyn Evan Caplin · 2014 · 1958 citations · Cited by this paper
- Patient Blood Management and Blood Product Alternatives · 2025 · Related
- DAXX / ATRX , MEN1 , and mTOR Pathway Genes Are Frequently Altered in Pancreatic Neuroendocrine Tumors · Yuchen Jiao · 2011 · 1732 citations · Cited by this paper
- Factor XIII Deficiency and Measurement · 2026 · Related
- Molecular subtypes of small cell lung cancer: a synthesis of human and mouse model data · Charles M. Rudin · 2019 · 1339 citations · Cited by this paper
- Platelet Subpopulations · 2025 · Related
- Gastroenteropancreatic neuroendocrine neoplasms: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up · Marianne Ellen Pavel · 2020 · 1196 citations · Cited by this paper
- A Triumvirate · 2026 · Related
- A common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal · Guido Rindi · 2018 · 1164 citations · Cited by this paper
- Scarless Surgery · 2026 · Related
- Altered Telomeres in Tumors with ATRX and DAXX Mutations · Christopher M. Heaphy · 2011 · 1107 citations · Cited by this paper
- Promoting Gender Equality in Pathology and Laboratory Medicine Leadership · 2025 · Related
- Predictive and prognostic factors for treatment and survival in 305 patients with advanced gastrointestinal neuroendocrine carcinoma (WHO G3): The NORDIC NEC study · Halfdan Sørbye · 2012 · 1039 citations · Cited by this paper
- Whole-genome landscape of pancreatic neuroendocrine tumours · Australian Pancreatic Cancer Genome Initiative · 2017 · 1033 citations · Cited by this paper
- Overview of the 2022 WHO Classification of Neuroendocrine Neoplasms · Guido Rindi · 2022 · 1032 citations · Cited by this paper
- ASCL1 and NEUROD1 Reveal Heterogeneity in Pulmonary Neuroendocrine Tumors and Regulate Distinct Genetic Programs · Mark D. Borromeo · 2016 · 547 citations · Cited by this paper
- Small Cell and Large Cell Neuroendocrine Carcinomas of the Pancreas are Genetically Similar and Distinct From Well-differentiated Pancreatic Neuroendocrine Tumors · Shinichi Yachida · 2012 · 544 citations · Cited by this paper
- SCLC Subtypes Defined by ASCL1, NEUROD1, POU2F3, and YAP1: A Comprehensive Immunohistochemical and Histopathologic Characterization · Marina K. Baine · 2020 · 532 citations · Cited by this paper
- Small Cell Lung Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology · Apar Kishor Ganti · 2021 · 494 citations · Cited by this paper
- Next-Generation Sequencing of Pulmonary Large Cell Neuroendocrine Carcinoma Reveals Small Cell Carcinoma–like and Non–Small Cell Carcinoma–like Subsets · Natasha Rekhtman · 2016 · 491 citations · Cited by this paper
- The High-grade (WHO G3) Pancreatic Neuroendocrine Tumor Category Is Morphologically and Biologically Heterogenous and Includes Both Well Differentiated and Poorly Differentiated Neoplasms · Olca Baştürk · 2015 · 489 citations · Cited by this paper
- Loss of DAXX and ATRX Are Associated With Chromosome Instability and Reduced Survival of Patients With Pancreatic Neuroendocrine Tumors · Ilaria Marinoni · 2013 · 466 citations · Cited by this paper
- Prognostic Factors in Pancreatic Endocrine Neoplasms: An Analysis of 136 Cases With a Proposal for Low-Grade and Intermediate-Grade Groups · Steven N. Hochwald · 2002 · 401 citations · Cited by this paper
- Pathologic analysis of carcinoidsHistologic re evaluation of 62 cases · Jun Soga · 1971 · 399 citations · Cited by this paper
- Small Cell Lung Carcinoma (SCLC) · Siobhan A. Nicholson · 2002 · 399 citations · Cited by this paper
- Characteristics and treatment of patients with G3 gastroenteropancreatic neuroendocrine neoplasms · Maximilian Heetfeld · 2015 · 396 citations · Cited by this paper
- Integrative genomic profiling of large-cell neuroendocrine carcinomas reveals distinct subtypes of high-grade neuroendocrine lung tumors · Julie George · 2018 · 389 citations · Cited by this paper
- A Practical Approach to the Classification of WHO Grade 3 (G3) Well-differentiated Neuroendocrine Tumor (WD-NET) and Poorly Differentiated Neuroendocrine Carcinoma (PD-NEC) of the Pancreas · Laura H. Tang · 2016 · 385 citations · Cited by this paper
- Well-Differentiated Neuroendocrine Tumors with a Morphologically Apparent High-Grade Component: A Pathway Distinct from Poorly Differentiated Neuroendocrine Carcinomas · Laura H. Tang · 2015 · 359 citations · Cited by this paper
- Pathology Reporting of Neuroendocrine Tumors: Application of the Delphic Consensus Process to the Development of a Minimum Pathology Data Set · David S. Klimstra · 2010 · 355 citations · Cited by this paper
- Gastroenteropancreatic high‐grade neuroendocrine carcinoma · Halfdan Sørbye · 2014 · 354 citations · Cited by this paper
Source: OpenAlex (CC0)